HD-OPM Archive
Topics › Brain health & dementia

Midlife hearing loss is a leading modifiable dementia risk factor, tied with LDL

Louis Nervegna · Aug 22, 2025 · ♥ 8 reactions · 5 comments · original Facebook post
Brain health & dementiaLDL, ApoB & lipid panel
AI summary & key facts

Louis says midlife hearing loss is, along with LDL, one of the two largest modifiable dementia risk factors and that treating it may reduce dementia risk. A shared JAMA Otolaryngology item estimates up to 32% of dementia cases are attributable to audiometric hearing loss.

Believe it or not, hearing loss in midlife is one of the two biggest modifiable risk factors for dementia. It is tied with LDL for being the biggest modifiable risk factor:

↪ Lancet Commission 2024: high LDL and hearing loss each account for 7% of dementia cases

↪ 2024 Lancet Commission: high LDL is the top modifiable dementia risk factor (7% of cases)

Treating hearing loss in midlife may significantly reduce your risk of developing dementia as you get older.

#dementiaHD #dementiahearingHD #alzheimersHD #hearingHD #ldldementiaHD

Research cited

Treating hearing loss could potentially delay dementia in older adults, with up to 32% of dementia cases attributable to audiometric hearing loss. Population Attributable Fraction of Incident Dementia Associated With Hearing Loss (JAMA Otolaryngol Head Neck Surg, 2025)

No photo description available.
← newer: Aging is the biggest risk factor for 9 of the top 10 causes older: 2024 Lancet Commission: untreated high LDL and hearing loss →